Literature DB >> 8808615

A somatic truncating mutation in BRCA2 in a sporadic breast tumor.

B H Weber, M Brohm, I Stec, J Backe, H Caffier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8808615      PMCID： PMC1914812     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  10 in total

1.  A somatic BRCA1 mutation in an ovarian tumour.

Authors:  L Hosking; J Trowsdale; H Nicolai; E Solomon; W Foulkes; G Stamp; E Signer; A Jeffreys
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

2.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

3.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

Authors:  R Wooster; S L Neuhausen; J Mangion; Y Quirk; D Ford; N Collins; K Nguyen; S Seal; T Tran; D Averill
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

4.  Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors.

Authors:  F Kerangueven; F Allione; T Noguchi; J Adélaïde; H Sobol; J Jacquemier; D Birnbaum
Journal:  Genes Chromosomes Cancer       Date:  1995-08       Impact factor: 5.006

5.  Mutation analysis in the BRCA2 gene in primary breast cancers.

Authors:  Y Miki; T Katagiri; F Kasumi; T Yoshimoto; Y Nakamura
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

6.  BRCA2 mutations in primary breast and ovarian cancers.

Authors:  J M Lancaster; R Wooster; J Mangion; C M Phelan; C Cochran; C Gumbs; S Seal; R Barfoot; N Collins; G Bignell; S Patel; R Hamoudi; C Larsson; R W Wiseman; A Berchuck; J D Iglehart; J R Marks; A Ashworth; M R Stratton; P A Futreal
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

7.  Low incidence of BRCA2 mutations in breast carcinoma and other cancers.

Authors:  D H Teng; R Bogden; J Mitchell; M Baumgard; R Bell; S Berry; T Davis; P C Ha; R Kehrer; S Jammulapati; Q Chen; K Offit; M H Skolnick; S V Tavtigian; S Jhanwar; B Swedlund; A K Wong; A Kamb
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

8.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Authors:  S V Tavtigian; J Simard; J Rommens; F Couch; D Shattuck-Eidens; S Neuhausen; S Merajver; S Thorlacius; K Offit; D Stoppa-Lyonnet; C Belanger; R Bell; S Berry; R Bogden; Q Chen; T Davis; M Dumont; C Frye; T Hattier; S Jammulapati; T Janecki; P Jiang; R Kehrer; J F Leblanc; J T Mitchell; J McArthur-Morrison; K Nguyen; Y Peng; C Samson; M Schroeder; S C Snyder; L Steele; M Stringfellow; C Stroup; B Swedlund; J Swense; D Teng; A Thomas; T Tran; M Tranchant; J Weaver-Feldhaus; A K Wong; H Shizuya; J E Eyfjord; L Cannon-Albright; M Tranchant; F Labrie; M H Skolnick; B Weber; A Kamb; D E Goldgar
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

9.  Protein truncation test (PTT) for rapid detection of translation-terminating mutations.

Authors:  P A Roest; R G Roberts; S Sugino; G J van Ommen; J T den Dunnen
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

10.  Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

Authors:  A M Cleton-Jansen; N Collins; S R Lakhani; J Weissenbach; P Devilee; C J Cornelisse; M R Stratton
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640
  10 in total
  7 in total

Review 1.  Fanconi anaemia: from a monogenic disease to sporadic cancer.

Authors:  Antonio Valeri; Sandra Martínez; José A Casado; Juan A Bueren
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

2.  Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.

Authors:  Gregory C Stachelek; Shibani Dalal; Katherine A Donigan; Denise Campisi Hegan; Joann B Sweasy; Peter M Glazer
Journal:  Cancer Res       Date:  2009-12-22       Impact factor: 12.701

3.  Germline BRCA2 mutations in men with breast cancer.

Authors:  E Mavraki; I C Gray; D T Bishop; N K Spurr
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity.

Authors:  Jianing Xi; Ao Li; Minghui Wang
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

5.  Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics.

Authors:  C Egawa; Y Miyoshi; T Taguchi; Y Tamaki; S Noguchi
Journal:  Jpn J Cancer Res       Date:  2001-06

6.  Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.

Authors:  Vahid R Yassaee; Sirous Zeinali; Iraj Harirchi; Soghra Jarvandi; Mohammad A Mohagheghi; David P Hornby; Ann Dalton
Journal:  Breast Cancer Res       Date:  2002-04-16       Impact factor: 6.466

7.  Identification of a novel germline BRCA2 variant in a Chinese breast cancer family.

Authors:  Jingliang Cheng; Jiangzhou Peng; Jiewen Fu; Md Asaduzzaman Khan; Pingping Tan; Chunli Wei; Xiyun Deng; Hanchun Chen; Junjiang Fu
Journal:  J Cell Mol Med       Date:  2019-11-28       Impact factor: 5.310
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.